I now have comprehensive content. Let me compile the full answer.
Macular Function Tests
Macular function tests assess the integrity of the central 20° of the visual field and the fovea specifically. They are used to screen for macular disease, differentiate macular from optic nerve pathology, and monitor disease progression.
1. Amsler Grid
The most commonly used bedside test for macular function.
Principle: Evaluates the central 20° of the visual field centred on fixation. It detects scotomas, metamorphopsia (distortion), and missing areas caused by macular disease.
Charts (7 available):
| Chart | Description | Use |
|---|
| 1 | White grid on black background, 400 small squares (each 5 mm = 1° at 33 cm) | Standard |
| 2 | Same as Chart 1 with diagonal lines | For patients with central scotoma (aids fixation) |
| 3 | Red squares on black background | Detects subtle colour scotomas, toxic maculopathy, optic neuropathy, chiasmal lesions |
| 4 | Random dots only | Distinguishes scotoma from metamorphopsia (no form to distort) |
| 5 | Horizontal lines | Detects metamorphopsia along specific meridians; useful in reading difficulty |
| 6 | White background, closer lines | More detailed metamorphopsia evaluation |
| 7 | Fine central grid (each square = 0.5°) | More sensitive for subtle central changes |
Technique:
- Pupils not dilated; performed before slit-lamp examination (to avoid photostress effect)
- Appropriate reading correction worn; chart held ~33 cm in good illumination
- One eye covered at a time
- Patient fixates the central dot and reports any distortion, waviness, blurring, or missing areas
- Patient outlines abnormal areas on the grid with a pencil
Interpretation:
- Metamorphopsia (wavy/distorted lines) → macular disease (e.g., AMD, epiretinal membrane, central serous retinopathy)
- Scotoma (missing area) → macular hole, choroidal neovascularisation
- Patients at risk of macular neovascularisation (MNV) should use an Amsler grid at home for regular self-monitoring
Fig. Amsler grid chart — patient fixates the central dot (Kanski's Clinical Ophthalmology)
Fig. Amsler grid with red central dot (The Wills Eye Manual)
2. Photostress Test (Macular Dazzle Test)
A gross test of dark adaptation at the foveal level.
Principle: Bright light bleaches foveal visual pigments, producing a temporary scotoma. Recovery depends on the ability of the retinal pigment epithelium (RPE) and photoreceptors to re-synthesise visual pigment. Since this process is metabolically dependent on RPE function, it is slowed in macular disease but not in optic nerve disease — making it a key differentiating test.
Indications:
- Maculopathy with equivocal ophthalmoscopic signs (e.g., mild cystoid macular oedema, central serous retinopathy)
- Differentiating macular disease from optic neuropathy as the cause of visual loss
Technique:
- Measure best-corrected distance visual acuity (BCVA) first
- Patient fixates on the light of a pen torch or indirect ophthalmoscope held ~3 cm from the eye for ~10 seconds
- Start timing immediately
- Photostress Recovery Time (PSRT) = time taken to read any 3 letters on the pre-test acuity line
- Repeat on the fellow (normal) eye for comparison
Interpretation:
| Finding | PSRT |
|---|
| Normal | 15–50 seconds |
| Macular disease | Prolonged (often >50 s, sometimes much longer) |
| Optic neuropathy | Normal / not significantly prolonged |
PSRT is prolonged in macular lesions but not in optic neuropathy — this is the key clinical distinguisher.
3. Light Brightness Comparison Test
Principle: Assesses relative afferent pupillary pathway function and perceived luminance asymmetry.
Technique:
- A bright light is shone into each eye alternately
- Patient rates the brightness in the affected eye relative to the normal eye (scale 1–5)
- In optic neuropathy, the light appears less bright in the affected eye
- Purely macular lesions cause minimal brightness asymmetry
4. Contrast Sensitivity Testing
Tests the ability to detect differences in luminance between an object and its background at various spatial frequencies.
- Assessed using the Pelli-Robson chart (rows of letters of decreasing contrast) or sinusoidal grating patterns
- More sensitive than standard Snellen acuity for detecting subtle macular or optic nerve dysfunction
- Reduced in macular disease, glaucoma, optic neuritis, and media opacity
5. Colour Vision Testing
Though primarily a test of optic nerve and cone function, colour vision tests are relevant to macular assessment:
- Ishihara plates: screen for red-green deficiency; mainly reflect macular function (as noted in Localization in Clinical Neurology)
- Farnsworth-Munsell 100 Hue and D-15: quantify the axis and severity of dyschromatopsia
- Acquired dyschromatopsia (especially red-green or blue-yellow) occurs in macular dystrophies, toxic maculopathy, and optic neuropathy
- Amsler Chart 3 (red squares) specifically targets colour scotomas in the macular region
6. Potential Acuity Meter (PAM) / Laser Interferometry
Used to estimate potential post-operative visual acuity when a cataract or other media opacity obscures the view of the macula.
- Projects a Snellen chart or grating directly onto the retina through a clear portion of the lens
- Useful when cataract surgery is being considered in an eye with possible posterior segment disease
- Limitation: PAM and laser interferometry overestimate visual potential in macular holes, pigment epithelial detachments, and amblyopia
- Near vision testing may be the most accurate method of evaluating macular function when the cataract is not too dense
7. Multifocal Electroretinogram (mfERG)
An electrophysiological test for objective assessment of macular function.
- Records retinal responses simultaneously from multiple locations across the macular region while the patient fixates a central target
- Generates a topographic map of retinal sensitivity across the central ~20–25°
- Detects focal areas of macular dysfunction not visible clinically
- Used in monitoring drug toxicity (e.g., hydroxychloroquine), macular dystrophies, and unexplained central visual loss
Summary Table
| Test | What it Measures | Key Use |
|---|
| Amsler Grid | Metamorphopsia, scotoma | Macular disease screening & monitoring |
| Photostress (PSRT) | RPE/photoreceptor recovery | Differentiates macular disease from optic neuropathy |
| Light Brightness Comparison | Perceived luminance symmetry | Optic neuropathy detection |
| Contrast Sensitivity | Luminance discrimination | Subtle macular or optic nerve dysfunction |
| Colour Vision | Cone/optic nerve function | Dyschromatopsia, toxic maculopathy |
| PAM / Laser Interferometry | Potential acuity through media opacity | Pre-cataract surgery macular assessment |
| mfERG | Topographic retinal electrical activity | Objective focal macular dysfunction |
Sources: Kanski's Clinical Ophthalmology, 10e; The Wills Eye Manual, 8e; Adams & Victor's Principles of Neurology, 12e; Localization in Clinical Neurology, 8e